Home
News
Create
Screeners
Insights
Star Imaging And Path Lab
74.
55
-1.78
(-2.33%)
Market Cap
₹129.90 Cr
PE Ratio
8.33
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-2.33%
1M
-13.73%
6M
-42.34%
1Y
-45.16%
5Y
-45.16%
View Company Insights
Latest news about Star Imaging And Path Lab
Star Imaging and Path Lab Limited Gets Empanelled with NIEPA for Medical Services
Jan 22, 2026
Star Imaging and Path Lab Limited has been empanelled by the National Institute of Educational Planning and Administration (NIEPA) to provide medical diagnostic and laboratory services to NIEPA employees at CGHS-approved rates. The empanelment remains valid until the company gets directly empanelled with the Central Government Health Scheme (CGHS). The company disclosed this development as part of regulatory compliance, noting it represents ordinary course of business and does not constitute a material financial impact.
Star Imaging and Path Lab Limited Secures 5-Year Empanelment with Indian National Science Academy
Jan 21, 2026
Star Imaging and Path Lab Secures Delhi High Court Medical Services Contract
Jan 21, 2026
Star Imaging And Path Lab: CERC Selects Co For Medical Services
Jan 14, 2026
Star Imaging and Path Lab Limited Receives ICSSR Empanelment for Medical Services
Jan 13, 2026
More news about Star Imaging And Path Lab
07
Jan 26
Star Imaging and Path Lab Secures Supreme Court Medical Services Contract
Star Imaging and Path Lab Limited has received approval from the Supreme Court of India to provide credit/cashless medical services to all serving officers, officials, and their dependent family members under CGHS norms. The company disclosed this development on January 7, 2026, classifying it as ordinary business operations without material financial impact. The arrangement will be governed by applicable laws, CGHS guidelines, and internal company policies.
11
Nov 25
Star Imaging and Path Lab Secures WDRA Empanelment for Medical Services
Star Imaging and Path Lab Limited has secured empanelment with the Warehousing Development and Regulatory Authority (WDRA) Government of India for providing medical diagnostic and laboratory services to officers, employees, and their dependents at CGHS approved rates. The three-year empanelment adds to the company's existing CGHS empanelment and advanced imaging facilities including CT scan and 3 Tesla MRI at its Vikaspuri center, strengthening its position in the diagnostic healthcare sector.
Star Imaging And Path Lab
74.
55
-
1.
78
(-
2.
33
%)
1 Year Returns:
-45.16%
Industry Peers
Dr. Lal Path Labs
1,402.30
(-
0.
45
%)
Vijaya Diagnostic Centre
1,008.90
(-
0.
06
%)
Metropolis Healthcare
1,860.10
(-
2.
07
%)
Thyrocare Technologies
399.45
(-
2.
02
%)
Nephrocare Health Services
558.85
(-
2.
14
%)
Krsnaa Diagnostics
642.10
(-
1.
09
%)
One Global Service Provider
757.95
(+
1.
37
%)
Suraksha Diagnostic
281.20
(+
0.
29
%)
3B BlackBio DX
1,617.95
(+
2.
84
%)
Sastasundar Ventures
284.90
(-
0.
19
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation